Ray Petrino

Ray Petrino

Ray began working with Pappas in January 2011 on a part-time basis, assisting Pappas with accounting, finance and operations activities. In January 2025, Ray transitioned into the CFO role.

Ray is the founder (2008) of Hemera Financial Solutions, LLC, a boutique firm that provides CFO expertise to consumer products, financial services, venture capital, and start-up companies. Ray served as the CFO for Phoundry Pharmaceuticals, acquired in its first year of operations. He served as the AICPA’s content matter expert for a variety of publications including “U.S. GAAP Financial Statements – Best Practices in Presentation and Disclosure,” providing users with the tools needed to apply the complex reporting guidance within U.S. GAAP. He served as a reviewer for “Auditing Derivative Instruments, Hedging Activities, and Investments in Securities – AICPA Audit Guide,” which provided "how-to" advice for auditing financial instruments.

In 2012, Ray was selected as a “40 Under 40″ award winner, an annual program that recognizes outstanding professionals for their contributions to their organizations and to the community. He founded Bowl Away CF (Cystic Fibrosis), which has raised over $220,000 for cystic fibrosis programs.

Prior to Hemera, Ray served as the Controller for Highland Financial Holdings Group, LLC and its HFH ShortPLUS Fund, a top performing hedge fund with net performance exceeding +140% in 2007. He served as the Controller for Shenkman Capital Management, Inc. and helped grow assets under management from $2 billion to $12 billion, while implementing the policies and procedures for the back office and supervising the audits of the onshore and offshore commingled funds. At Arthur Andersen, Ray completed the fieldwork requirements to later become a Certified Public Accountant (CPA) and worked on engagements such as The Hershey Company, Leslie Fay, and MaxMara.

Education:

University of Notre Dame (BBA in Accountancy)

Vicky McCauley

Vicky joined Pappas Capital in April 2023 as an Administrative Assistant.  Her administrative background includes providing support in the fields of executive recruiting, software, municipal government, and insurance and investment services.  She also provides bookkeeping support for her church.  Prior to joining Pappas Capital, Vicky worked with Focus Search Partners as a Project Coordinator.

Education:

Seattle Pacific University (BA, European Studies)

Lisa Dreyer

Lisa joined Pappas Ventures in November 2010 on a part-time basis to assist with accounting, finance and fundraising activities. She transitioned to full time in October 2014 and was named Senior Associate, Operations.

Prior to joining Pappas, Lisa was a Vice President in the Alternative Investments Group of the J.P. Morgan Private Bank in New York. She was co-head of Investor Relations, responsible for managing all investor communication to the firm’s high net worth clients with respect to their private equity, hedge fund and real estate investments. She was also responsible for providing updates to clients on the performance of their alternative investment portfolios. Prior to the J.P. Morgan Private Bank, Lisa was a Vice President at J.P. Morgan Capital, the firm’s proprietary private equity unit. She worked directly for the COO and assisted in the formation of J.P. Morgan’s first employee co-investment program. Before that, Lisa served as controller for J.P. Morgan Capital. She began her career in the J.P. Morgan Financial division as part of the firm’s financial reporting group.

Education:

New York University Stern School of Business (MBA in Finance)
Utica College of Syracuse University (BS in Accounting)

Glenda Crumpler

Glenda joined Pappas Capital in September 2018 as Executive Administrative Assistant. She has over 20 years of experience utilizing strong problem solving and organization skills to support operational and administrative functions in the pharmaceutical and technology industries. Prior to joining Pappas Capital, Glenda worked at Greenwich Biosciences supporting the Vice President of Clinical Sciences and US Regulatory teams, and managing the RTP office. Glenda has also supported executive leadership at Pfizer, King Pharmaceuticals and Cisco Systems.